Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Major facilitator superfamily domain-containing protein 10 (MFSD10) is a member of the major facilitator superfamily of transporters. It is primarily expressed in the kidney, localizing to the luminal membrane of proximal tubules, where it functions as a transporter for organic anions, including the non-steroidal anti-inflammatory drugs indomethacin and diclofenac. MFSD10 is capable of both efflux and uptake, thus influencing the renal excretion and systemic pharmacokinetics of substrate drugs. Overexpression of MFSD10 confers cellular resistance to specific NSAIDs, indicating an efflux pump function akin to its yeast orthologue TPO1. The transporter’s activity may impact drug bioavailability and side effects, and its molecular structure supports its role as part of the major facilitator superfamily.
Efflux pump for organic anions and NSAIDs: confers drug resistance by transporting them out of cells, reducing intracellular concentration. Uptake/facilitation of renal excretion: mediates transport into the tubular lumen for excretion.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Major facilitator superfamily domain-containing protein 10 (MFSD10).